Sanofi Winthrop Industry
PolandAll medications by this manufacturer
-
Calcium resonium
Form: powder for oral use or for preparation of rectal suspension
Active substance Dosage calcium polystyrene sulfonate 99.934 g/100 g ATC: V03AE01
-
Cordarone
Form: tablets
Active substance Dosage amiodarone hydrochloride 200 mg ATC: C01BD01
-
Cordarone
Form: tablets
Active substance Dosage amiodarone hydrochloride 200 mg ATC: C01BD01
-
Cordarone
Form: tablets
Active substance Dosage amiodarone hydrochloride 200 mg ATC: C01BD01
-
Dalfaz sr 5
Form: tablets, film-coated, prolonged release
Active substance Dosage alfuzosin hydrochloride 5 mg ATC: G04CA01
-
Dalfaz uno
Form: tablets, prolonged release
Active substance Dosage alfuzosin hydrochloride 10 mg ATC: G04CA01
-
Depakine
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC: N03AG01
-
Depakine
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC: N03AG01
-
Depakine
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Sodium valproate 400 mg ATC: N03AG01
-
Depakine chronosphere 100
Form: granules, prolonged release
Active substance Dosage Sodium valproate 66.66 mg Valproic acid 29.03 mg ATC: N03AG01
-
Depakine chronosphere 1000
Form: granules, prolonged release
Active substance Dosage sodium valproate 666.6 mg valproic acid 290.27 mg ATC: N03AG01
-
Depakine chronosphere 250
Form: granules, prolonged release
Active substance Dosage Sodium valproate 166.76 mg Valproic acid 72.61 mg ATC: N03AG01
-
Depakine chronosphere 500
Form: granules, prolonged release
Active substance Dosage Sodium valproate 333.3 mg Valproic acid 145.14 mg ATC: N03AG01
-
Depakine chronosphere 750
Form: granules, prolonged release
Active substance Dosage Sodium valproate 500.06 mg Valproic acid 217.75 mg ATC: N03AG01
-
Efluelda
Form: solution for injection in ampoule-syringe
Active substance Dosage trivalent inactivated influenza vaccine (split virion) No input provided ATC: J07BB02
-
Efluelda tetra
Form: solution for injection in ampoule-syringe
Active substance Dosage Inactivated influenza vaccine A/Victoria/4897/2022 (H1N1)pdm09 60 micrograms HA Inactivated influenza vaccine A/Thailand/8/2022 (H3N2) 60 micrograms HA Inactivated influenza vaccine B/Austria/1359417/2021 60 micrograms HA Inactivated influenza vaccine B/Phuket/3073/2013 60 micrograms HA ATC: J07BB02
-
Fludara
Form: tablets, film-coated
Active substance Dosage fludarabine phosphate 10 mg ATC: L01BB05
-
Resonium a
Form: powder for oral use or for preparation of rectal suspension
Active substance Dosage sodium polystyrene sulfonate 99.934 g ATC: V03AE01
-
Solian
Form: tablets, film-coated
Active substance Dosage amisulpride 400 mg ATC: N05AL05
-
Solian
Form: tablets, film-coated
Active substance Dosage amisulpride 400 mg ATC: N05AL05
-
Tritace 10
Form: tablets
Active substance Dosage ramipril 10 mg ATC: C09AA05
-
Tritace 10
Form: tablets
Active substance Dosage ramipril 10 mg ATC: C09AA05
-
Tritace 10
Form: tablets
Active substance Dosage ramipril 10 mg ATC: C09AA05
-
Tritace 10
Form: tablets
Active substance Dosage ramipril 10 mg ATC: C09AA05
-
Tritace 5
Form: tablets
Active substance Dosage ramipril 5 mg ATC: C09AA05
-
Tritace 5
Form: tablets
Active substance Dosage ramipril 5 mg ATC: C09AA05